Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Nanomedicine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Market Overview:

The global nanomedicine market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 10% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end-use sectors. These insights are included in the report as a major market contributor.

Nanomedicine refers to specialized multi-functional drugs with programmable properties used for the treatment of diseases and repairing tissues at a molecular level. It involves the use of nanoparticles, nanotubes and nanodevices, such as imaging agents, nanorobots, biochips and polymer therapeutics, for the diagnosis, treatment and prevention of a disorder and analyzing the underlying pathophysiology. The nanoparticles include metal and metal oxides, liposomes and inorganic particles, which are used for transporting the drugs and targeting difficult to reach areas in the body. As a result, nanomedicine finds extensive applications for drug delivery, diagnostic imaging, vaccines, regenerative medicines and implants.

Nanomedicine Market Trends:

The increasing prevalence of chronic medical ailments across the globe is one of the key factors creating a positive outlook for the market. Nanomedicine is highly beneficial in the treatment of oncological, neurological, urological, infectious, ophthalmological, orthopedic, immunological and cardiovascular diseases. Moreover, as the coronavirus disease (COVID-19) continues to spread across the globe, there has been a significant increase in the demand for nanomedicines to produce vaccines and nanocarrier systems with enhanced efficacies. In line with this, shifting preference for personalized medicines is also contributing to the growth of the market. Additionally, various technological advancements in the nanoscale technologies for improved diagnostic procedures are acting as other growth-inducing factors. Pharmaceutical manufacturers are using nanorobotic systems and other novel solutions for the effective administration of nanomedicines. Other factors, including improvements in the healthcare infrastructure, along with extensive research and development (R&D) activities in the field of biotechnology, are anticipated to drive the market toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global nanomedicine market report, along with forecasts for growth at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, nanomolecule type, product and application.

Breakup by Nanomolecule Type:

  • Nanoparticles
    • Metal and Metal Oxide Nanoparticles
    • Liposomes
    • Polymers and Polymer Drug Conjugates
    • Hydrogel Nanoparticles
    • Dendrimers
    • Inorganic Nanoparticles
  • Nanoshells
  • Nanotubes
  • Nanodevices
     

Breakup by Product:

  • Therapeutics
  • Regenerative Medicine
  • In-Vitro diagnostics
  • In-Vivo diagnostics
  • Vaccines
     

Breakup by Application:

  • Clinical Oncology
  • Infectious Diseases
  • Clinical Cardiology
  • Orthopedics
  • Others
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Arrowhead Pharmaceuticals Inc., General Electric Company, Luminex Corporation, Merck & Co. Inc., Nanobiotix, Novartis AG, Pfizer Inc., Sanofi SA and Starpharma Holdings Limited.

Report Coverages:

Report Features Details
Base Year of the Analysis 2020
    Historical Period 2015-2020
Forecast Period 2021-2026
Units US$ Billion
Segment Coverage Nanomolecule Type, Product, Application, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Abbott Laboratories, Arrowhead Pharmaceuticals Inc., General Electric Company, Luminex Corporation, Merck & Co. Inc., Nanobiotix, Novartis AG, Pfizer Inc., Sanofi SA and Starpharma Holdings Limited.
Customization Scope 10% Free Customization
Report Price and Purchase Option                                     Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Key Questions Answered in This Report:

  • How has the global nanomedicine market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global nanomedicine market?
  • What are the key regional markets?
  • What is the breakup of the market based on the nanomolecule type?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the application?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global nanomedicine market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Nanomedicine Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Nanomolecule Type
    6.1    Nanoparticles
        6.1.1 Market Trends
        6.1.2 Major Types
           6.1.2.1 Metal and Metal Oxide Nanoparticles
           6.1.2.2 Liposomes
           6.1.2.3 Polymers and Polymer Drug Conjugates
           6.1.2.4 Hydrogel Nanoparticles
           6.1.2.5 Dendrimers
           6.1.2.6 Inorganic Nanoparticles
        6.1.3 Market Forecast
    6.2    Nanoshells
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Nanotubes
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    Nanodevices
        6.4.1 Market Trends
        6.4.2 Market Forecast
7    Market Breakup by Product
    7.1    Therapeutics
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Regenerative Medicine
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    In-Vitro Diagnostics
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    In-Vivo Diagnostics
        7.4.1 Market Trends
        7.4.2 Market Forecast
    7.5    Vaccines
        7.5.1 Market Trends
        7.5.2 Market Forecast
8    Market Breakup by Application
    8.1    Clinical Oncology
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Infectious Diseases
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Clinical Cardiology
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Orthopedics
        8.4.1 Market Trends
        8.4.2 Market Forecast
    8.5    Others
        8.5.1 Market Trends
        8.5.2 Market Forecast
9    Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia-Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10    SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11    Value Chain Analysis
12    Porters Five Forces Analysis

    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13    Price Analysis
14    Competitive Landscape

    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    Abbott Laboratories
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio
           14.3.1.3 Financials
           14.3.1.4 SWOT Analysis
        14.3.2    Arrowhead Pharmaceuticals Inc.
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio
           14.3.2.3 Financials
           14.3.2.4 SWOT Analysis
        14.3.3    General Electric Company
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio
           14.3.3.3 Financials
        14.3.4    Luminex Corporation
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio
           14.3.4.3 Financials
           14.3.4.4 SWOT Analysis
        14.3.5    Merck & Co. Inc.
           14.3.5.1 Company Overview
           14.3.5.2 Product Portfolio
           14.3.5.3 Financials
           14.3.5.4 SWOT Analysis
        14.3.6    Nanobiotix
           14.3.6.1 Company Overview
           14.3.6.2 Product Portfolio
           14.3.6.3 Financials
        14.3.7    Novartis AG
           14.3.7.1 Company Overview
           14.3.7.2 Product Portfolio
           14.3.7.3 Financials
           14.3.7.4 SWOT Analysis
        14.3.8    Pfizer Inc.
           14.3.8.1 Company Overview
           14.3.8.2 Product Portfolio
           14.3.8.3 Financials
           14.3.8.4 SWOT Analysis
        14.3.9    Sanofi SA
           14.3.9.1 Company Overview
           14.3.9.2 Product Portfolio
           14.3.9.3 Financials
           14.3.9.4 SWOT Analysis
        14.3.10    Starpharma Holdings Limited
           14.3.10.1 Company Overview
           14.3.10.2 Product Portfolio
           14.3.10.3 Financials

List of Figures

Figure 1: Global: Nanomedicine Market: Major Drivers and Challenges
Figure 2: Global: Nanomedicine Market: Sales Value (in Billion US$), 2015-2020
Figure 3: Global: Nanomedicine Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 4: Global: Nanomedicine Market: Breakup by Nanomolecule Type (in %), 2020
Figure 5: Global: Nanomedicine Market: Breakup by Product (in %), 2020
Figure 6: Global: Nanomedicine Market: Breakup by Application (in %), 2020
Figure 7: Global: Nanomedicine Market: Breakup by Region (in %), 2020
Figure 8: Global: Nanomedicine (Nanoparticles) Market: Sales Value (in Million US$), 2015 & 2020
Figure 9: Global: Nanomedicine (Nanoparticles) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 10: Global: Nanomedicine (Nanoshells) Market: Sales Value (in Million US$), 2015 & 2020
Figure 11: Global: Nanomedicine (Nanoshells) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 12: Global: Nanomedicine (Nanotubes) Market: Sales Value (in Million US$), 2015 & 2020
Figure 13: Global: Nanomedicine (Nanotubes) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 14: Global: Nanomedicine (Nanodevices) Market: Sales Value (in Million US$), 2015 & 2020
Figure 15: Global: Nanomedicine (Nanodevices) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 16: Global: Nanomedicine (Therapeutics) Market: Sales Value (in Million US$), 2015 & 2020
Figure 17: Global: Nanomedicine (Therapeutics) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 18: Global: Nanomedicine (Regenerative Medicine) Market: Sales Value (in Million US$), 2015 & 2020
Figure 19: Global: Nanomedicine (Regenerative Medicine) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 20: Global: Nanomedicine (In-Vitro Diagnostics) Market: Sales Value (in Million US$), 2015 & 2020
Figure 21: Global: Nanomedicine (In-Vitro Diagnostics) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 22: Global: Nanomedicine (In-Vivo Diagnostics) Market: Sales Value (in Million US$), 2015 & 2020
Figure 23: Global: Nanomedicine (In-Vivo Diagnostics) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 24: Global: Nanomedicine (Vaccines) Market: Sales Value (in Million US$), 2015 & 2020
Figure 25: Global: Nanomedicine (Vaccines) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 26: Global: Nanomedicine (Clinical Oncology) Market: Sales Value (in Million US$), 2015 & 2020
Figure 27: Global: Nanomedicine (Clinical Oncology) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 28: Global: Nanomedicine (Infectious Diseases) Market: Sales Value (in Million US$), 2015 & 2020
Figure 29: Global: Nanomedicine (Infectious Diseases) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 30: Global: Nanomedicine (Clinical Cardiology) Market: Sales Value (in Million US$), 2015 & 2020
Figure 31: Global: Nanomedicine (Clinical Cardiology) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 32: Global: Nanomedicine (Orthopedics) Market: Sales Value (in Million US$), 2015 & 2020
Figure 33: Global: Nanomedicine (Orthopedics) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 34: Global: Nanomedicine (Other Applications) Market: Sales Value (in Million US$), 2015 & 2020
Figure 35: Global: Nanomedicine (Other Applications) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 36: North America: Nanomedicine Market: Sales Value (in Million US$), 2015 & 2020
Figure 37: North America: Nanomedicine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 38: United States: Nanomedicine Market: Sales Value (in Million US$), 2015 & 2020
Figure 39: United States: Nanomedicine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 40: Canada: Nanomedicine Market: Sales Value (in Million US$), 2015 & 2020
Figure 41: Canada: Nanomedicine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 42: Asia-Pacific: Nanomedicine Market: Sales Value (in Million US$), 2015 & 2020
Figure 43: Asia-Pacific: Nanomedicine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 44: China: Nanomedicine Market: Sales Value (in Million US$), 2015 & 2020
Figure 45: China: Nanomedicine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 46: Japan: Nanomedicine Market: Sales Value (in Million US$), 2015 & 2020
Figure 47: Japan: Nanomedicine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 48: India: Nanomedicine Market: Sales Value (in Million US$), 2015 & 2020
Figure 49: India: Nanomedicine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 50: South Korea: Nanomedicine Market: Sales Value (in Million US$), 2015 & 2020
Figure 51: South Korea: Nanomedicine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 52: Australia: Nanomedicine Market: Sales Value (in Million US$), 2015 & 2020
Figure 53: Australia: Nanomedicine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 54: Indonesia: Nanomedicine Market: Sales Value (in Million US$), 2015 & 2020
Figure 55: Indonesia: Nanomedicine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 56: Others: Nanomedicine Market: Sales Value (in Million US$), 2015 & 2020
Figure 57: Others: Nanomedicine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 58: Europe: Nanomedicine Market: Sales Value (in Million US$), 2015 & 2020
Figure 59: Europe: Nanomedicine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 60: Germany: Nanomedicine Market: Sales Value (in Million US$), 2015 & 2020
Figure 61: Germany: Nanomedicine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 62: France: Nanomedicine Market: Sales Value (in Million US$), 2015 & 2020
Figure 63: France: Nanomedicine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 64: United Kingdom: Nanomedicine Market: Sales Value (in Million US$), 2015 & 2020
Figure 65: United Kingdom: Nanomedicine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 66: Italy: Nanomedicine Market: Sales Value (in Million US$), 2015 & 2020
Figure 67: Italy: Nanomedicine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 68: Spain: Nanomedicine Market: Sales Value (in Million US$), 2015 & 2020
Figure 69: Spain: Nanomedicine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 70: Russia: Nanomedicine Market: Sales Value (in Million US$), 2015 & 2020
Figure 71: Russia: Nanomedicine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 72: Others: Nanomedicine Market: Sales Value (in Million US$), 2015 & 2020
Figure 73: Others: Nanomedicine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 74: Latin America: Nanomedicine Market: Sales Value (in Million US$), 2015 & 2020
Figure 75: Latin America: Nanomedicine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 76: Brazil: Nanomedicine Market: Sales Value (in Million US$), 2015 & 2020
Figure 77: Brazil: Nanomedicine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 78: Mexico: Nanomedicine Market: Sales Value (in Million US$), 2015 & 2020
Figure 79: Mexico: Nanomedicine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 80: Others: Nanomedicine Market: Sales Value (in Million US$), 2015 & 2020
Figure 81: Others: Nanomedicine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 82: Middle East and Africa: Nanomedicine Market: Sales Value (in Million US$), 2015 & 2020
Figure 83: Middle East and Africa: Nanomedicine Market: Breakup by Country (in %), 2020
Figure 84: Middle East and Africa: Nanomedicine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 85: Global: Nanomedicine Industry: SWOT Analysis
Figure 86: Global: Nanomedicine Industry: Value Chain Analysis
Figure 87: Global: Nanomedicine Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Nanomedicine Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Nanomedicine Market Forecast: Breakup by Nanomolecule Type (in Million US$), 2021-2026
Table 3: Global: Nanomedicine Market Forecast: Breakup by Product (in Million US$), 2021-2026
Table 4: Global: Nanomedicine Market Forecast: Breakup by Application (in Million US$), 2021-2026
Table 5: Global: Nanomedicine Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 6: Global: Nanomedicine Market: Competitive Structure
Table 7: Global: Nanomedicine Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2299

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links